Therapeutics: Estrogen receptor β

Cancer

INDICATION: Cancer

In vitro and mouse studies have identified salicylketoxime-based estrogen receptor β-selective agonists

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE